News

21/07/2021

New plasma biomarker to detect Alzheimer’s disease in Down syndrome individuals

International collaboration led by researchers at the Sant Pau Reseach Institute – IIB Sant Pau in Barcelona, Spain, shows effectiveness of a plasma biomarker to detect Alzheimer’s Disease in Down...

08/07/2021

Large genomic analysis highlights COVID-19 risk factors

An international collaboration uncovers several genetic markers associated with SARS-CoV-2 infection and COVID-19 severity. These results, which have been published in Nature, come from one of the la...

14/06/2021

New biomarkers in blood are identified for the prognosis of abdominal aortic aneurysm risk

Blood and vascular levels of various molecules related to oxidative stress can be good predictors of aneurysm rupture.  The research, developed by researchers from the Research Institute o...

20/05/2021

Professor Lina Badimon joins the Royal Academy of Medicine of Catalonia

Professor Lina Badimón, head of the group of Molecular and Therapeutic Pathology of Atherothrombotic and Ischemic Diseases of the Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB ...

30/04/2021

Robotic device that induces hallucinations allows scientists to identify the brain network responsible for hallucinations in Parkinson’s disease

A team of researchers at the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, together with scientists at École Polythecnique Fédérale de Lausanne (EPFL), describe t...